Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Ocean Biomedical, Inc. OCEA OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score
34/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Ocean Biomedical, Inc. (OCEA) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 3 Buy.

OCEA Analyst Ratings

Buy
3
Ratings
3 Buy
Based on 3 analysts giving stock ratings to Ocean Biomedical, Inc. in the past 3 months
Rating breakdown
Buy
3 100%
100%
Buy
3 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

People Also View

ZURA
ZURA
Zura Bio Limited
$5.72
+0.70%
 ELEV
ELEV
Elevation Oncology, Inc.
$0.37
-2.12%
 AVRO
AVRO
AVROBIO, Inc.
$1.40
-1.41%
 CWBR
CWBR
CohBar, Inc.
$0.41
+0.00%
 ENVB
ENVB
Enveric Biosciences, Inc.
$1.95
-1.02%
 HEPA
HEPA
Hepion Pharmaceuticals, Inc.
$0.05
+18.52%
 EFTR
EFTR
eFFECTOR Therapeutics, Inc.
$0.00
+0.00%
 LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message